Nuvectis Pharma Retained Earnings (Accumulated Deficit) 2021-2024 | NVCT

Nuvectis Pharma retained earnings (accumulated deficit) from 2021 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Nuvectis Pharma Retained Earnings (Accumulated Deficit) 2021-2024 | NVCT

Nuvectis Pharma retained earnings (accumulated deficit) from 2021 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.